CA2000695A1 - Cytokine - Google Patents
CytokineInfo
- Publication number
- CA2000695A1 CA2000695A1 CA 2000695 CA2000695A CA2000695A1 CA 2000695 A1 CA2000695 A1 CA 2000695A1 CA 2000695 CA2000695 CA 2000695 CA 2000695 A CA2000695 A CA 2000695A CA 2000695 A1 CA2000695 A1 CA 2000695A1
- Authority
- CA
- Canada
- Prior art keywords
- cells
- monokine
- hours
- factor
- macrophage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2833—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPJ3248 | 1989-03-16 | ||
| AUPJ324889 | 1989-03-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2000695A1 true CA2000695A1 (fr) | 1990-09-16 |
Family
ID=3773786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2000695 Abandoned CA2000695A1 (fr) | 1989-03-16 | 1989-10-13 | Cytokine |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA2000695A1 (fr) |
| WO (1) | WO1990010650A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5198428A (en) * | 1991-04-05 | 1993-03-30 | Board Of Regents, The Univ. Of Texas System | Macrophage cytotoxin compositions and methods of preparation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60105621A (ja) * | 1983-11-14 | 1985-06-11 | Agency Of Ind Science & Technol | 細胞の分化誘導作用を有する生理活性物質およびその製法 |
| US4923807A (en) * | 1984-05-18 | 1990-05-08 | New England Medical Center Hospitals Inc. | Arg-Serpin human plasminogen activator inhibitor designated PAI-2 |
| FR2596651B1 (fr) * | 1986-04-08 | 1989-11-10 | Centre Nat Rech Scient | Nouveaux liposomes a base de phosphatidylinositolmannosides, et compositions pharmaceutiques les contenant |
| FR2615622B1 (fr) * | 1987-05-19 | 1994-05-06 | Ire Medgenix Sa | Dosage plasmatique de monokines |
| JPS6490199A (en) * | 1987-09-30 | 1989-04-06 | Hiromi Fujiwara | T cell growth factor derived from thymic interstitial cell and production thereof |
| JPH01132381A (ja) * | 1987-11-19 | 1989-05-24 | Kyodo Nyugyo Kk | ヘパリチナーゼ及びその製造法 |
-
1989
- 1989-10-13 CA CA 2000695 patent/CA2000695A1/fr not_active Abandoned
- 1989-10-13 WO PCT/AU1989/000453 patent/WO1990010650A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1990010650A1 (fr) | 1990-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Blanton et al. | Regulation of interleukin 1 and its receptor in human keratinocytes. | |
| Togawa et al. | Characterization of lymphocyte-activating factor (LAF) produced by human mononuclear cells: biochemical relationship of high and low molecular weight forms of LAF | |
| CA2086264C (fr) | Complexes de lymphotoxine de surface | |
| Lefrancois et al. | Antigen-independent activation of memory cytotoxic T cells by interleukin 2. | |
| Kaka et al. | Using dendritic cell maturation and IL-12 producing capacity as markers of function: a cautionary tale | |
| MXPA01010332A (es) | Metodos y composiciones para modular una respuesta inmunitaria. | |
| Suttles et al. | T cell rescue of monocytes from apoptosis: role of the CD40-CD40L interaction and requirement for CD40-mediated induction of protein tyrosine kinase activity | |
| CA2125181A1 (fr) | Interferons trophoblastiques et leur utilisation | |
| Dayton et al. | Role of immune interferon in the monocytic differentiation of human promyelocytic cell lines induced by leukocyte conditioned medium | |
| JP2006312640A (ja) | T細胞活性化 | |
| Grufman et al. | Innate and adaptive immunity to tumors: IL‐12 is required for optimal responses | |
| Danielsson et al. | Effect of cytokines on specific in vitro immunization of human peripheral B lymphocytes against T-cell dependent antigens | |
| Borges et al. | Peptide‐based analysis of the amino acid sequence important to the immunoregulatory function of Trypanosoma cruzi Tc52 virulence factor | |
| CA2000695A1 (fr) | Cytokine | |
| Nissen-Meyer et al. | Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity | |
| Germann et al. | Requirements for the growth of TH1 lymphocyte clones | |
| Peleg et al. | 1, 25-Dihydroxyvitamin D3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1beta production. | |
| Sorg | Modulation of macrophage functions by lymphokines | |
| Krane | Collagen degradation | |
| Heemskerk et al. | Differential activation of mouse hepatitis virus-specific CD4+ cytotoxic T cells is defined by peptide length | |
| Cavaillon et al. | Presence of IL 1 activity in the supernatant of human monocytes challenged with purified allergenic constituents | |
| Snyderman et al. | Biologic aspects of leukocyte chemotaxis | |
| Hirayama et al. | Accessory cell functions of dendritic cells and macrophages in the thymic T-cell response to Con A | |
| Cohen et al. | Adherent Ia+ murine cell lines with characteristics of dendritic cells: II. Characteristics of I region-restricted antigen presentation | |
| Parra et al. | Inhibition of mitogenesis induced by phytohemagglutinin and Lens culinaris lectin in adherent-cell supernatants treated with protein extract of Mycobacterium tuberculosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |